$PLMJ
Plum Acquisition Corp. III

2022 Q4 Form 10-K Financial Statement

#000119312523103685 Filed on April 17, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $4.075M
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $947.9K $2.813M
YoY Change 101.76% 269.33%
Operating Profit -$2.813M
YoY Change
Interest Expense $2.390M $4.075M
YoY Change 39929.98% 48875.12%
% of Operating Profit
Other Income/Expense, Net $844.1K $7.794M
YoY Change -3197.76% 530.73%
Pretax Income $2.286M $9.056M
YoY Change -565.51% 1777.35%
Income Tax
% Of Pretax Income
Net Earnings $2.286M $9.056M
YoY Change -565.51% 1777.35%
Net Earnings / Revenue 222.24%
Basic Earnings Per Share
Diluted Earnings Per Share $0.06 $0.25
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $726.9K $726.9K
YoY Change -65.78% -65.78%
Cash & Equivalents $726.9K
Short-Term Investments
Other Short-Term Assets $194.0K $194.0K
YoY Change -43.0% -43.0%
Inventory
Prepaid Expenses $193.9K
Receivables
Other Receivables
Total Short-Term Assets $920.8K $920.8K
YoY Change -62.64% -62.64%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $286.6M $286.6M
YoY Change 1.44% 1.44%
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $286.6M $286.6M
YoY Change 1.37% 1.37%
TOTAL ASSETS
Total Short-Term Assets $920.8K $920.8K
Total Long-Term Assets $286.6M $286.6M
Total Assets $287.5M $287.5M
YoY Change 0.82% 0.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $38.87K $54.24K
YoY Change -25.92% -46.16%
Accrued Expenses $1.214M $1.214M
YoY Change 1212.49% 1212.49%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.269M $1.269M
YoY Change 556.42% 556.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.37M $10.37M
YoY Change -42.91% -42.91%
Total Long-Term Liabilities $10.37M $10.37M
YoY Change -42.91% -42.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.269M $1.269M
Total Long-Term Liabilities $10.37M $10.37M
Total Liabilities $11.64M $11.64M
YoY Change -36.6% -36.6%
SHAREHOLDERS EQUITY
Retained Earnings -$10.72M
YoY Change -31.73%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.72M $275.9M
YoY Change
Total Liabilities & Shareholders Equity $287.5M $287.5M
YoY Change 0.82% 0.82%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $2.286M $9.056M
YoY Change -565.51% 1777.35%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$277.2K -$1.397M
YoY Change 8.56% 26.65%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -277.2K -1.397M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 0.000
Net Change In Cash -277.2K -1.397M
YoY Change 13.8% -165.78%
FREE CASH FLOW
Cash From Operating Activities -$277.2K -$1.397M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001845550
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40677
CY2022 dei Entity Registrant Name
EntityRegistrantName
ALPHA PARTNERS TECHNOLOGY MERGER CORP.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1581691
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
Empire State Building
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 4215
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
CY2022 dei City Area Code
CityAreaCode
852
CY2022 dei Local Phone Number
LocalPhoneNumber
2523 1056
CY2022 dei Security12b Title
Security12bTitle
Class A ordinary shares included as part of the Units, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
APTM
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
283871250
CY2022 dei Auditor Firm
AuditorFirmId
688
CY2022 dei Auditor Name
AuditorName
Marcum, LLC
CY2022 dei Auditor Location
AuditorLocation
Houston, Texas
CY2022 aptm Threshold Number Of Business Days For Redemption
ThresholdNumberOfBusinessDaysForRedemption
P10D
CY2021Q3 aptm Warrants Issued Per Private Placement Unit
WarrantsIssuedPerPrivatePlacementUnit
0.33
CY2022 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants
CY2022Q4 us-gaap Cash
Cash
726869
CY2021Q4 us-gaap Cash
Cash
2124185
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
193947
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
340290
CY2022Q4 us-gaap Assets Current
AssetsCurrent
920816
CY2021Q4 us-gaap Assets Current
AssetsCurrent
2464475
CY2022Q4 aptm Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
0
CY2021Q4 aptm Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
193947
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
286583051
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
282508321
CY2022Q4 us-gaap Assets
Assets
287503867
CY2021Q4 us-gaap Assets
Assets
285166743
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
38866
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
52466
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
15377
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
48273
CY2022Q4 aptm Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
1214321
CY2021Q4 aptm Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
92515
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1268564
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
193254
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
482367
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
8276150
CY2022Q4 aptm Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
9887500
CY2021Q4 aptm Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
9887500
CY2022Q4 us-gaap Liabilities
Liabilities
11638431
CY2021Q4 us-gaap Liabilities
Liabilities
18356904
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
286583051
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
282508321
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10718408
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15699275
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10717615
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-15698482
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
287503867
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
285166743
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2812916
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
761634
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2812916
us-gaap Operating Income Loss
OperatingIncomeLoss
-761634
CY2022 aptm Expensed Offering Costs
ExpensedOfferingCosts
0
aptm Expensed Offering Costs
ExpensedOfferingCosts
540944
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
4074730
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
8321
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7793783
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2807641
CY2022 aptm Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
0
aptm Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
-69334
CY2022 aptm Gain On Expiration Of Overallotment Option Liability
GainOnExpirationOfOverallotmentOptionLiability
0
aptm Gain On Expiration Of Overallotment Option Liability
GainOnExpirationOfOverallotmentOptionLiability
67345
CY2022 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
0
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-1213542
CY2022 aptm Gain On Forfeiture Of Founder Warrants
GainOnForfeitureOfFounderWarrants
0
aptm Gain On Forfeiture Of Founder Warrants
GainOnForfeitureOfFounderWarrants
45834
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9055597
us-gaap Net Income Loss
NetIncomeLoss
482355
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
16667
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8353042
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
24542225
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
8321
us-gaap Net Income Loss
NetIncomeLoss
482355
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-15698482
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
4074730
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9055597
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10717615
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9055597
us-gaap Net Income Loss
NetIncomeLoss
482355
CY2022 aptm Expensed Offering Costs
ExpensedOfferingCosts
0
aptm Expensed Offering Costs
ExpensedOfferingCosts
540944
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
4074730
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
8321
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7793783
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2807641
CY2022 aptm Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
0
aptm Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
-69334
CY2022 aptm Gain On Expiration Of Overallotment Option Liability
GainOnExpirationOfOverallotmentOptionLiability
0
aptm Gain On Expiration Of Overallotment Option Liability
GainOnExpirationOfOverallotmentOptionLiability
67345
CY2022 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
0
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-1213542
CY2022 aptm Gain On Forfeiture Of Founder Warrants
GainOnForfeitureOfFounderWarrants
0
aptm Gain On Forfeiture Of Founder Warrants
GainOnForfeitureOfFounderWarrants
45834
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-340290
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
534237
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13600
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
51785
CY2022 aptm Increase Decrease In Accrued Liabilities Related Parties
IncreaseDecreaseInAccruedLiabilitiesRelatedParties
-32896
aptm Increase Decrease In Accrued Liabilities Related Parties
IncreaseDecreaseInAccruedLiabilitiesRelatedParties
48273
CY2022 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
1121806
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
92515
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1397316
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1103298
CY2022 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
282500000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-282500000
CY2022 aptm Proceeds From Advance From Anchor Investor
ProceedsFromAdvanceFromAnchorInvestor
0
aptm Proceeds From Advance From Anchor Investor
ProceedsFromAdvanceFromAnchorInvestor
501362
CY2022 aptm Repayment Of Advance From Anchor Investor
RepaymentOfAdvanceFromAnchorInvestor
0
aptm Repayment Of Advance From Anchor Investor
RepaymentOfAdvanceFromAnchorInvestor
500681
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
178167
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
178167
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
278019000
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
8650000
CY2022 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
0
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
25000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
967198
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
285727483
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1397316
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2124185
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2124185
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
726869
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2124185
CY2022 aptm Accretion Of Class A Ordinary Shares To Redemption Amount
AccretionOfClassAOrdinarySharesToRedemptionAmount
4074730
aptm Accretion Of Class A Ordinary Shares To Redemption Amount
AccretionOfClassAOrdinarySharesToRedemptionAmount
24550546
CY2022 aptm Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
0
aptm Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
9887500
CY2022 aptm Forfeiture Of Classb Ordinary Shares
ForfeitureOfClassbOrdinaryShares
0
aptm Forfeiture Of Classb Ordinary Shares
ForfeitureOfClassbOrdinaryShares
13
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-02-05
CY2021Q3 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
282500000
CY2021Q3 aptm Terms Of Restricted Investments
TermsOfRestrictedInvestments
P185D
CY2022Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10
CY2022Q4 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2022Q4 aptm Percentage Of Temporary Equity Redemption Restriction
PercentageOfTemporaryEquityRedemptionRestriction
0.15
CY2022Q4 aptm Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination
PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination
1
CY2022 aptm Combination Period
CombinationPeriod
P24M
CY2022Q4 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000
CY2022Q4 us-gaap Cash
Cash
726869
CY2022Q4 aptm Working Capital
WorkingCapital
-347748
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates. The initial valuation of the Public Warrants (as defined in Note 3) and Class A ordinary shares subject to redemption, and the quarterly valuation of the Private Placement Warrants (as defined in Note 4) required management to exercise significant judgement in its estimates.</div>
CY2022Q4 us-gaap Cash
Cash
726869
CY2021Q4 us-gaap Cash
Cash
2124185
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
aptm Fair Value Of Proceeds From Issuance Of Common Stock
FairValueOfProceedsFromIssuanceOfCommonStock
272895000
aptm Equity Reduction Due To Offering Costs
EquityReductionDueToOfferingCosts
-14937225
aptm Initial Equity Accretion To Redemption Value Adjustment
InitialEquityAccretionToRedemptionValueAdjustment
24542225
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
8321
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
282508321
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
4074730
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
286583051
aptm Stock Issuance Costs
StockIssuanceCosts
16641377
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
5650000
CY2022Q4 aptm Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
9887500
aptm Other Offering Costs
OtherOfferingCosts
967198
aptm Offering Costs Recognised As A Reduction Of Temporary Equity
OfferingCostsRecognisedAsAReductionOfTemporaryEquity
14937225
aptm Expensed Offering Costs
ExpensedOfferingCosts
540944
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021Q3 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (“Public Warrant”).
CY2022Q4 aptm Working Capital Loan Outstanding
WorkingCapitalLoanOutstanding
0
CY2021Q4 aptm Working Capital Loan Outstanding
WorkingCapitalLoanOutstanding
0
CY2022 aptm Class Of Warrants Or Rights Issued During The Period Units
ClassOfWarrantsOrRightsIssuedDuringThePeriodUnits
9705000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
7793783
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2807641

Files In Submission

Name View Source Status
0001193125-23-103685-index-headers.html Edgar Link pending
0001193125-23-103685-index.html Edgar Link pending
0001193125-23-103685.txt Edgar Link pending
0001193125-23-103685-xbrl.zip Edgar Link pending
aptm-20221231.xsd Edgar Link pending
d444687d10k.htm Edgar Link pending
d444687dex311.htm Edgar Link pending
d444687dex312.htm Edgar Link pending
d444687dex321.htm Edgar Link pending
d444687dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
d444687d10k_htm.xml Edgar Link completed
aptm-20221231_def.xml Edgar Link unprocessable
aptm-20221231_pre.xml Edgar Link unprocessable
aptm-20221231_cal.xml Edgar Link unprocessable
aptm-20221231_lab.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending